387 related articles for article (PubMed ID: 22644979)
1. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
Li E; Trovato JA
Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.
Vadhan-Raj S; Goldberg JD; Perales MA; Berger DP; van den Brink MR
J Cell Mol Med; 2013 Nov; 17(11):1371-84. PubMed ID: 24251854
[TBL] [Abstract][Full Text] [Related]
3. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
[TBL] [Abstract][Full Text] [Related]
4. [Use of laser for the prevention and treatment of oral mucositis induced by radiotherapy and chemotherapy for head and neck cancer].
Muñoz-Corcuera M; González-Nieto A; López-Pintor Muñoz RM
Med Clin (Barc); 2014 Aug; 143(4):170-5. PubMed ID: 24216016
[TBL] [Abstract][Full Text] [Related]
5. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
[TBL] [Abstract][Full Text] [Related]
6. Cancer treatment-induced oral mucositis: a critical review.
Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL
Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451
[TBL] [Abstract][Full Text] [Related]
7. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.
Scully C; Epstein J; Sonis S
Head Neck; 2004 Jan; 26(1):77-84. PubMed ID: 14724910
[TBL] [Abstract][Full Text] [Related]
8. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
[TBL] [Abstract][Full Text] [Related]
9. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis.
Campos TM; do Prado Tavares Silva CA; Sobral APT; Sobral SS; Rodrigues MFSD; Bussadori SK; Fernandes KPS; Mesquita-Ferrari RA; Horliana ACRT; Motta LJ
Support Care Cancer; 2020 Dec; 28(12):5649-5659. PubMed ID: 32666214
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation.
Weigelt C; Haas R; Kobbe G
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):505-15. PubMed ID: 21417820
[TBL] [Abstract][Full Text] [Related]
11. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
12. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
Beaven AW; Shea TC
Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
[TBL] [Abstract][Full Text] [Related]
14. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer.
Shih A; Miaskowski C; Dodd MJ; Stotts NA; MacPhail L
Oncol Nurs Forum; 2002 Aug; 29(7):1063-80. PubMed ID: 12183755
[TBL] [Abstract][Full Text] [Related]
15. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
16. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
[TBL] [Abstract][Full Text] [Related]
17. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
18. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
19. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
[TBL] [Abstract][Full Text] [Related]
20. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
